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Abstract
Background:  Bone morphogenetic proteins (BMPs) and transforming growth factor-β s (TGF-β s)
are important regulators of bone repair and regeneration. BMP-2 and TGF-β 1 have been shown to
inhibit gap junctional intercellular communication (GJIC) in MC3T3-E1 cells. Connexin 43 (Cx43)
has been shown to mediate GJIC in osteoblasts and it is the predominant gap junctional protein
expressed in these murine osteoblast-like cells. We examined the expression, phosphorylation, and
subcellular localization of Cx43 after treatment with BMP-2 or TGF-β 1 to investigate a possible
mechanism for the inhibition of GJIC.
Results:  Northern blot analysis revealed no detectable change in the expression of Cx43 mRNA.
Western blot analysis demonstrated no significant change in the expression of total Cx43 protein.
However, significantly higher ratios of unphosphorylated vs. phosphorylated forms of Cx43 were
detected after BMP-2 or TGF-β 1 treatment. Immunofluorescence and cell protein fractionation
revealed no detectable change in the localization of Cx43 between the cytosol and plasma
membrane.
Conclusions:  BMP-2 and TGF-β 1 do not alter expression of Cx43 at the mRNA or protein level.
BMP-2 and TGF-β 1 may inhibit GJIC by decreasing the phosphorylated form of Cx43 in MC3T3-
E1 cells.
Introduction
Bone morphogenetic protein-2 (BMP-2) and transform-
ing growth factor-β 1 (TGF-β 1), members of the TGF-β
superfamily, play important roles in bone repair and re-
generation [1–4]. BMPs, defined as osteoinductive by
their ability to induce osteogenesis when implanted in
extraskeletal sites, are thought to mediate the transfor-
mation of undifferentiated mesenchymal cells into bone-
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producing osteoblasts. BMP-2 and TGF-β 1 promote os-
teogenesis in vivo and have been applied exogenously to
accelerate healing of bony defects in various animal
models [5–8].
Gap junctional intercellular communication (GJIC) rep-
resents one mechanism of cell-cell communication and
has been implicated in the maintenance of intercellular
homeostasis and regulation of signals during embryo-
genesis, differentiation, growth, and regeneration [9–
11]. Gap junctions have been shown by electron micros-
copy to exist between osteoblasts and osteocytes in ho-
mologous and heterologous cell populations [12–14].
Gap junctions are thought to be essential for maintaining
skeletal integrity and coordinating repair of osseous tis-
sue by propagating intracellular signals generated in re-
sponse to soluble factors, such as epidermal growth
factor (EGF) and basic fibroblast growth factor (bFGF),
or mechanical stimuli, such as cyclic stretch [15–18].
Connexins are the structural subunits of gap junctions
[19] and connexin 43 (Cx43) has been shown to mediate
intercellular communication in osteoblasts [20].
In a previous study, we reported that BMP-2 or TGF-β 1
markedly inhibited GJIC in the murine-derived MC3T3-
E1 cell [21]. Cx43 is the predominant gap junctional pro-
tein expressed in this cell line and we hypothesized that
Cx43 mediated intercellular communication in these os-
teoblast-like cells. In this study, we describe the effects of
BMP-2 and TGF-β 1 on the expression, phosphorylation,
and subcellular localization of Cx43 in MC3T3-E1 cells.
Results
Effects of BMP-2 and TGF-β 1 on Cx43 mRNA Expression
Northern blot analysis revealed no significant difference
in the steady state level of Cx43 mRNA after treatment
with BMP-2 or TGF-β 1 at either 24 or 48 h when stand-
ardized to GAPDH as control (Fig. 1).
Effects of BMP-2 and TGF-β 1 on Cx43 Protein Expression 
and Phosphorylation
Western blot analysis with anti-Cx43 antibody revealed
prominent bands at 43 kD and 46 kD (Fig. 2). The addi-
tion of ALP increased the density of the 43 kD band in
comparison to the 46 kD band in all groups (Fig. 2, even-
numbered lanes).
After 24 and 48 h of BMP-2 treatment, there was no sig-
nificant change in total Cx43 protein expression. Howev-
er, BMP-2 treatment increased the density of the 43 kD
band relative to the 46 kD band at 24 h, and at 48 h (Fig.
2, lane 3). This effect was accentuated with the addition
of ALP.
At 48 h, TGF-β 1 slightly increased total Cx43 protein ex-
pression but markedly increased the density of the 43 kD
band compared to the 46 kD band (Fig. 2, lanes 5 and 6),
resulting in a significant increase in the 43 kD: 46 kD ra-
tio (Fig. 3). This increase in the Cx43 43 kD: 46 kD iso-
form ratio was magnified in the presence of ALP. The
effect of TGF-β 1 at 24 h was similar but not statistically
significant compared to control. Densitometric analyses
of total protein expression and the 43 kD: 46 kD Cx43
isoform ratio are summarized in Fig. 3.
Effects of BMP-2 and TGF-β 1 on Cx43 Localization
Immunofluorescence revealed Cx-43-specific staining
intracellularly and on the cell surface. We did not ob-
serve any difference in localization after treatment with
BMP-2 or TGF-β 1 with this modality (Fig. 4, top panel).
TGF-β 1-treated cells exhibited an elongated shape com-
pared to the control and BMP-2-treated groups.
Figure 1
Effects of BMP-2 and TGF-β 1 on Cx43 mRNA expression. A.
Northern blots demonstrating Cx43 expression for control,
BMP-2, and TGF-β 1 groups after 24-h and 48-h treatments
(top panel), with GAPDH control (bottom panel). B.
Graphic representation of Cx43 mRNA expression normal-
ized to GAPDH.BMC Cell Biology (2001) 2:14 http://www.biomedcentral.com/1471-2121/2/14
Cell protein fractionation revealed that Cx43 protein was
more abundant in the cytosolic fraction than the mem-
brane fraction for both untreated and treated cells. There
was no significant difference in the distribution of Cx43
between the cytosol and plasma membrane after BMP-2
and TGF-β 1 treatment (Fig. 4, bottom panel)
Discussion
The MC3T3-E1 cell has been proposed as an in vitro
model of osteoblastic differentiation and maturation
[22,23] and is widely utilized in osteoblast functional
studies. In previous studies, we reported that BMP-2 or
TGF-β 1 treatment as well as multiple cell passages inhib-
ited GJIC in these clonal osteoblast-like cells [21,24].
Since Cx43 has been shown to mediate cell-cell commu-
nication in human osteoblasts [20], we hypothesized
that Cx43 may be an important mediator of GJIC in
murine-derived MC3T3-E1 cells.
Northern blot analysis revealed no detectable change in
the steady state level of Cx43 mRNA expression after
treatment with BMP-2 and TGF-β 1. Western blot analy-
sis showed that the addition of ALP to untreated control
groups increased the density of the 43 kD protein, while
decreasing the density of the 46 kD isoform (Fig. 2, lanes
1 and 2). This effect was blunted in the presence of oka-
daic acid, a phosphatase inhibitor (data not shown),
strongly suggesting that the 43 kD and 46 kD bands rep-
resent the unphosphorylated and phosphorylated forms
of Cx43, respectively [25]. All samples were tested with
and without ALP, as previously described, to confirm the
phosphorylated isoform, represented by the 46 kD band.
The addition of ALP increased the unphosphorylated
form (43 kD band) as would be expected.
There was no significant change in the expression of total
Cx43 protein. However, both BMP-2 and TGF-β 1 in-
creased the density of the 43 kD protein compared to
control at 24 h and 48 h (Fig. 2.). These effects were ac-
centuated with the addition of ALP. When expressed as a
43 kD: 46 kD band ratio, both BMP-2 and TGF-β 1 signif-
icantly increased the ratio of the unphosphorylated:
phosphorylated forms of Cx43 at 24 h and 48 h, respec-
tively (Fig. 3.).
Immunofluorescence studies showed no observable dif-
ference in the localization of Cx43 after BMP-2 or TGF-
β 1 treatment. Cells treated with TGF-β 1 developed an
elongated, spindle shape which was a phenomenon re-
ported in our previous study [21]. Since immunofluores-
cence studies may have lacked the sensitivity to
distinguish minor changes in Cx43 redistribution, cell
protein fractionation based on detergent solubility was
performed. Immunoprecipitation of the cytosolic and
membrane-bound protein fractions also showed no sig-
nificant change in the distribution of Cx43 protein be-
tween the cytosol and plasma membrane. Both of these
assays suggest there is no significant alteration in the
distribution of Cx43 associated with BMP-2 or TGF-β 1
treatment.
Figure 2
Effects of BMP-2 and TGF-β 1 on the expression and phos-
phorylation of Cx43 protein. Western analysis of Cx43 pro-
tein expression for control, BMP-2, and TGF-β 1 groups after
treatment for 24 h (top panel) and 48 h (bottom panel) in the
absence (-) or presence (+) of ALP. Experiments suggest that
43 kD and 46 kD bands represent the unphosphorylated and
phosphorylated forms of Cx43, respectively.
Figure 3
Densitometric analysis of Cx43 expression. Total Cx43 pro-
tein expression (left) and the ratio of the 43 kD: 46 kD bands
(right) normalized to control levels. Values are mean ± S.D.
of 3 separate experiments with control set at 100% 
(* p < 0.05 compared to control).BMC Cell Biology (2001) 2:14 http://www.biomedcentral.com/1471-2121/2/14
The phosphorylation of Cx43 has been implicated in gap
junction assembly and gating events [25–27]. Musil and
Goodenough previously reported that communication-
deficient cells demonstrated no detectable amounts of
the Cx43-P2 isoform (biphosphorylated Cx43) while cells
with low gap junctional permeability had detectable
amounts of the Cx43-P1 isoform (monophosphorylated
Cx43). They speculated that Cx43 phosphorylation cor-
related positively with cell coupling [25]. Our study also
suggests that a decrease in the phosphorylated form of
Cx43 (or conversely, an increase in ratio of unphosphor-
ylated: phosphorylated Cx43 forms) may be associated
with GJIC inhibition after BMP-2 or TGF-β 1 treatment.
It is unclear whether phosphorylation of Cx43 is inhibit-
ed or dephosphorylation of Cx43-P2 or Cx43-P1 is en-
hanced. The specific signaling mechanism of BMP-2 or
TGF-β 1 action is not yet defined and is currently under
investigation.
GJIC is an important mechanism of cell-cell communica-
tion and has been shown to modulate gene expression in
osteoblastic cells [28]. The regulatory signals that
traverse gap junctions have yet to be defined and may
consist of both stimulatory and inhibitory signals [10].
BMP-2 and TGF-β 1 have been shown to inhibit GJIC in
MC3T3-E1 cells and their effects may be mediated by
changes in the phosphorylation of Cx43. The identifica-
tion of specific signaling pathways and regulatory ac-
tions of BMP-2 and TGF-β 1 in MC3T3-E1 cells will be
important in understanding the role of intercellular com-
munication in bone biology.
Conclusions
BMP-2 and TGF-β 1 do not alter expression of Cx43 at the
mRNA or protein level. BMP-2 and TGF-β 1 may inhibit
GJIC by decreasing the phosphorylated form of Cx43 in
MC3T3-E1 cells.
Materials and Methods
Materials
The MC3T3-E1 cell line was a generous gift from Dr.
Gideon Rodan (Merck, Sharpe and Dohme, West Point,
PA). Purified human TGF-β 1 was purchased from Up-
state Biotechnology, Inc. (Lake Placid, NY). Recom-
binant human BMP-2 and rat heart Cx43 cDNA were
generously provided by Dr. Gerard Reidel (Genetics In-
stitute, Cambridge, MA) and Dr. David Paul (Harvard
Medical School, Cambridge, MA), respectively. CT-360,
a site-directed antibody to the C-terminal amino acids
from positions 360 to 382 of the connexin 43 molecule
derived from rat cardiac tissue, was generated in rabbit
and was a most generous gift of Dr. Dale Laird (Califor-
nia Institute of Technology, Pasadena, CA).
Cell culture
MC3T3-E1 cells were plated at 5,000/cm2 on plastic 25
cm2 culture flasks or 10 cm2 round dishes (Costar, Cam-
bridge, MA) or 25 mm2 round glass coverslips in α -MEM
medium (Sigma, St. Louis, MO) supplemented with 5%
fetal bovine serum, 26 mM NaHCO3, 2 mM glutamine,
100 units/ml penicillin, and 100 µg/ml streptomycin,
and grown in humidified 5% C02/95% air at 37°C. Cells
were passaged every 3–4 days after releasing with
0.002% pronase E in phosphate buffered saline (PBS).
Cells were not used beyond passage number 40.
MC3T3-E1 cells in treatment groups were grown for 24
h, then incubated with BMP-2 (50 ng/ml) or TGF-β 1 (2.0
ng/ml) dissolved in PBS containing 4 mM HCl and 0.1%
bovine serum albumin (BSA) at 37°C for 24 and 48 h.
Control groups received equal volumes of vehicle only
(PBS with 4 mM HCl and 0.1% BSA).
Northern blot analysis
MC3T3-E1 total RNA was prepared using an acid gua-
nidinium isothiocyanate-phenol-chloroform extraction
method [29]. Sample concentration was estimated by
optical density (OD) at 260 nm. 20 µg of total RNA per
lane were fractionated by electrophoresis on a formalde-
hyde-containing 1% agarose gel and transferred onto Du-
ralon membranes (Stratagene, La Jolla, CA). Northern
blots were hybridized with random primer radiolabeled
(Megaprime, Amersham) rat heart Cx43 and GAPDH
(control) cDNAs in Rapid-hyb buffer (Amersham Phar-
macia Biotech, Piscataway, NJ) at 60°C overnight. The
blots were washed at moderate stringency and autoradi-
ographs were analyzed with densitometry.
Figure 4
Subcellular localization of Cx43. MC3T3-E1 cells were
treated with A. PBS vehicle (control), B. BMP-2, or C. TGF-
β 1 for 48 h. Immunofluorescent localization of Cx43 visual-
ized with epifluorescence microscopy (top panel). Immuno-
precipitation of Cx43 in cytosolic (left lanes) and
membranous (right lanes) fractions.BMC Cell Biology (2001) 2:14 http://www.biomedcentral.com/1471-2121/2/14
Western blot analysis
MC3T3-E1 cell samples were lysed in 0.5 ml of RIPA
buffer with slight modification (150 mM NaCl, 2 mM ED-
TA, 2 mM PMSF, 50 mM Tris-HCl, pH 7.4). 10 mM leu-
peptin and 2 mM sodium orthovanadate were added in
the calf intestinal alkaline phosphatase (ALP) treatment
groups. Cell lysates were sonicated (three 15 second puls-
es) and centrifuged at 4°C for 20 min. The protein con-
centration of each sample was determined by the
Bradford method [30] using a BioRad protein assay kit
(BioRad Laboratories, Hercules, CA). After alkaliniza-
tion with NaOH to pH 9.7, one-half of each sample was
treated with 1:500 diluted calf intestinal alkaline phos-
phatase (Sigma, St. Louis, MO) at 37°C for 3 h, and the
other half was treated under the same conditions in the
absence of ALP to demonstrate the phosphorylated iso-
form. The reaction was terminated by adding EDTA and
heating the samples to 75°C for 10 min. 20 µg of total
protein from each sample were separated using 10%
SDS-polyacrylamide gel electrophoresis and transferred
to Immobilon-P membranes (Millipore, Malborough,
MA). The western blots were preincubated in blocking
solution (5% nonfat milk, 0.2% Tween-20, 0.02% sodi-
um azide in PBS, pH 7.4) at room temperature and
probed with the primary anti-Cx43 polyclonal antibody
(1:300 dilution; antibody against Cx43 C-terminus) for 1
h. The membranes were washed, incubated with the
horseradish peroxidase-linked goat anti-rabbit IgG sec-
ondary antibody (Amersham), and developed using a
chemiluminescence system (ECL kit, Amersham). Auto-
radiographs were analyzed with densitometry.
Cx43 immunofluorescence
MC3T3-E1 cells were cultured on 22 mm2 glass cover-
slips and treated with BMP-2 or TGF-β 1. The cells were
fixed with 50% methanol/50% acetone at room temper-
ature for 2 min, 1 ml of 0.1% Triton X-100 for 5 min, fol-
lowed by three washes in PBS. The coverslips were
incubated in blocking buffer for 45 min and probed with
the anti-Cx43 polyclonal antibody (1:50 dilution) at
room temperature for 1 h. Goat anti-rabbit IgG second-
ary antibody conjugated to DTAF was used to visualize
the immunolocalized Cx43. The coverslips were mount-
ed on glass slides using Permount medium (Fisher Scien-
tific, Irvine, CA) and randomly viewed and imaged using
epifluorescence microscopy with a blue-green filter set.
Fractionation and immunoprecipitation of Cx43
MC3T3-E1 cells were pre-incubated in methionine and
cysteine-free culture medium for 45 min and labeled
with 35S -methionine/35S-cysteine (ICN Biomedicals, Ir-
vine, CA) at 37°C for 2 h. Cells were lysed in RIPA buffer
as described above, incubated at 4°C for 10 min, vor-
texed, and collected in a microfuge tube on ice. The
lysates were incubated and solubilized with 20% Triton
X-100 at 4°C for 30 min and centrifuged. The membrane
protein fraction was separated from the cytosolic frac-
tion and reconstituted in RIPA buffer. Using the anti-
Cx43 polyclonal antibody, Cx43 protein was immuno-
precipitated, resolved with SDS-polyacrylamide gel elec-
trophoresis (SDS-PAGE), and visualized by
autoradiography.
Statistical Analysis
Mean ± S.D. was calculated from each of two or more in-
dependent experiments. One way analysis of variance
(ANOVA) followed by student's t test was used to deter-
mine significance (p < 0.05).
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